Novo Nordisk Fights to Keep Medicaid Paying for Weight-Loss Drugs
Posted2 months agoActive2 months ago
reuters.comOtherstory
skepticalnegative
Debate
20/100
HealthcarePharmaceuticalsMedicaid
Key topics
Healthcare
Pharmaceuticals
Medicaid
Novo Nordisk is fighting to keep Medicaid covering its weight-loss drugs, raising concerns about the financial burden on the program and the role of pharmaceutical companies in shaping healthcare policy.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
4m
Peak period
1
0-1h
Avg / period
1
Key moments
- 01Story posted
Oct 27, 2025 at 8:51 PM EDT
2 months ago
Step 01 - 02First comment
Oct 27, 2025 at 8:54 PM EDT
4m after posting
Step 02 - 03Peak activity
1 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Oct 27, 2025 at 8:54 PM EDT
2 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
Discussion (1 comments)
Showing 1 comments
toomuchtodo
2 months ago
Medicaid should import it from Canada as soon as the patent expires next year.
View full discussion on Hacker News
ID: 45728161Type: storyLast synced: 11/17/2025, 8:06:15 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.